LactaLogics, Inc.
Port Saint Lucie, Florida, 34952, United States
NCT Number: NCT04492579
This study evaluates the effects of providing breastfeeding mothers with Gentle-UHT donor human milk (GHM) after discharge to bridge the gap during delayed onset lactation, to support an exclusive human milk diet and continued breastfeeding through the infant's first week of life. The investigators aim to determine the safety of GHM, and if GHM provided to breastfeeding mothers of outpatient babies with early weight loss will ensure babies adequately gain weight according to age-matched controls.
Looking for future studies?
Notify MeUp to 4 day
All sexes
Interventional
Not applicable
Port Saint Lucie, Florida, 34952, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Providers referred mothers with newborns that fit the following criteria: exhibited insufficient milk supply, an infant with early weight loss born >36 weeks gestation. Mother was given Gentle-UHT donor milk for supplementation, in addition to mother's own milk for the first week of the infant's life after hospital discharge.
Time frame: 8-9 days of life
Average weights compared to WHO data
Time frame: 8-9 days of life
Rates of infants still on an exclusive human milk diet
LactaLogics, Inc
Industry
Neonates Supplemented With Gentle-UHT Donor Human Milk in the First Week of Life
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06350071
Acute Pain, Behavior
Burdur, Bucak, Turkey (Türkiye)
View Trial DetailsNCT06944054
Newborns
Ankara, Turkey (Türkiye)
View Trial DetailsNCT06387888
Neurologic Manifestations, Newborns
Istanbul, Beykoz, Turkey (Türkiye)
View Trial DetailsNCT03637894
Innate Immunity, Microbiota
Milan, Italy
View Trial Details